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Abstract: Oral biofilms are functionally and structurally organized polymicrobial communities 
that are embedded in an extracellular matrix of exopolymers on mucosal and dental surfaces. 
These biofilms are found naturally in health, and provide benefits to the host. However, this rela-
tionship can break down, and disease can occur; disease is associated with a shift in the balance 
of the species within these biofilms. Simple diagnostic tests have been developed that involve 
the culture of selected bacteria, eg, those implicated in dental caries, facilitating an assessment 
of risk of further disease in individual patients. However, oral diseases have a complex etiol-
ogy, and because only around 50% of oral biofilm can be grown at present, culture-independent 
molecular-based approaches are being developed that give a more comprehensive assessment 
of the presence of a range of putative pathogens in samples. The diversity of these biofilms cre-
ates challenges in the interpretation of findings, and future work is investigating the ability of 
novel techniques to detect biological activity and function in oral biofilms, rather than simply 
providing a catalogue of microbial names.
Keywords: oral biofilms, dental plaque, dental diagnostics, molecular techniques, polymerase 
chain reaction, next-generation sequencing
Introduction
The prevalence of oral diseases has a considerable economical impact on health care 
provision across the world; for example, dental caries affects over 80% of the population 
in many countries,1 so has a significant impact on quality of life, as well as implications 
for systemic health.2 Indeed, chronic oral infections have been associated with diabetes 
and cardiovascular disease,3,4 as well as stomach ulcers and gastric cancer.5
The microbial etiology of dental diseases has been extensively studied; however, the 
complex nature and diverse composition of oral biofilms makes it difficult to identify 
the causative micro-organisms. Despite early theories focusing on identifying a single 
pathogen responsible for oral diseases such as dental caries, gingivitis, and chronic perio-
dontitis, it is now generally accepted that these diseases result from the concerted actions 
of multispecies microbial communities. Conventional culture methods have tradition-
ally been used to characterize the oral microbiota; however, a large proportion remains 
unculturable, leading to an incomplete understanding of natural microbial communities.6 
Also, even when isolation of culturable organisms is achievable, one must be aware that 
a single species might behave differently under laboratory conditions than when it is 
in its natural habitat.7 Nonetheless, oral biofilms have long been the best characterized 
(and accessible) complex biofilms of relevance to human health and disease, but despite 
this, there still seems to be no effective approach to prevent oral diseases.8 The study of 
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microbial communities within their own natural environment 
is essential to improve our knowledge of the disease process. 
Microbial ecology holds great potential for the development 
of new approaches to control oral biofilms, and for identify-
ing novel preventive and therapeutic strategies. The enhance-
ment of traditional microbial culture methods with the use of 
molecular tools has allowed a more thorough characterization 
of the human microbiome in general, especially that of the 
gut,9,10 but also of the oral cavity,11 even though it has been 
mostly focused on assessment of the diversity rather than the 
functionality of bacterial communities.
In this review, we report on the complex structure and 
development of oral biofilms in health and disease, and 
describe the molecular tools that are currently available for 
their analysis. We also discuss the advantages and limita-
tions as well as the impact of such techniques on the future 
of patient care.
Background
The mouth, like other habitats in the body, is colonized by a 
characteristic and complex microbiota that grows as diverse 
biofilms on all mucosal and dental surfaces. This microbiota 
comprises protozoa, yeasts, mycoplasmas, Archaea, and 
bacteria, with the latter being the most numerous and diverse 
group. Only about half of these bacteria are currently cultur-
able, and the application of culture-independent approaches 
has led to the detection of at least 1200 taxa,11 although an 
individual mouth harbors only a subset of these, and typically 
around 100 species.
The composition of microbiota varies on different sur-
faces due to the prevailing physical and biological condi-
tions at distinct sites. The microbial load at mucosal sites is 
relatively low due to desquamation, although biofilms with 
a higher microbial density and diversity are found on the 
highly papillated surface of the tongue. In contrast, because 
they are nonshedding surfaces, teeth permit accumulation 
of the greatest amount of biomass in the mouth; the highest 
numbers and the greatest diversity of micro-organisms are 
found at stagnant sites which afford protection from oral 
removal forces. Fissures on occlusal surfaces have high 
numbers of aerobic and facultatively anaerobic, saccharolytic 
Gram positive bacteria, especially streptococci, and there are 
few anaerobes or Gram negative organisms. In contrast, the 
gingival crevice has the highest proportions of proteolytic 
and obligately anaerobic bacteria, many of which are Gram 
negative and some of which are unculturable. Saliva contains 
up to 108 micro-organisms per mL that are derived from other 
oral surfaces, especially the tongue.12
Once established, the composition of microbial 
communities at a site remains relatively constant over time, 
and this natural balance is termed “microbial homeostasis”. In 
general, the resident oral microbiota coexists in a harmonious 
relationship with the host, and makes important contributions 
to the normal development and general health of the host. It 
supports the innate and adaptive host defenses in excluding 
exogenous (and often pathogenic) micro-organisms, and is 
responsible for the natural development of the physiology of 
the host. However, on occasions, this harmonious relationship 
can breakdown, and disease can occur. In caries, there are 
increases in acidogenic and acid-tolerating species such as 
mutans streptococci, lactobacilli, and bifidobacteria, while 
in periodontal disease, the subgingival biofilm has elevated 
levels of proteolytic bacteria that subvert the host inflam-
matory response.12 The predominant bacteria at inflamed 
sites include obligately anaerobic and often Gram negative 
bacteria, including, for example, representatives of the genera 
Prevotella, Porphyromonas, Fusobacterium, Treponema, 
and Tannerella, and there is also an increased proportion of 
unculturable taxa.
Development of dental biofilms
Micro-organisms have to attach to oral surfaces if they are to 
persist in the mouth. The oral microbiota grows as interactive 
microbial communities on mucosal and dental surfaces in 
the form of structurally and functionally organized biofilms. 
The development of biofilms has been reviewed recently.13–16 
All surfaces of the mouth are covered by a layer of adsorbed 
molecules of bacterial and salivary origin (termed the 
acquired pellicle), and the initial colonizing bacteria attach 
to this layer. Initially, these “pioneer” species are held revers-
ibly through weak, long-range physicochemical interactions 
between charged molecules on the cell and oral surfaces. 
This interaction can become permanent via strong, short-
range stereochemical interactions between adhesins on the 
bacterium and complementary receptors in the acquired 
pellicle. These early colonizers are generally streptococci, 
and as they grow, they modify the local environment and 
make conditions suitable for colonization by more fastidi-
ous organisms. Secondary colonizers attach to receptors on 
these already attached bacteria (coadhesion), and gradually 
the diversity of the biofilm increases over time to form a 
multispecies community. The attached bacteria synthesize 
a range of extracellular polymers to form a biofilm matrix; 
this matrix is more than a structural scaffold because it 
can retain and bind many molecules, including enzymes, 
and so is biologically active.17 The bacteria interact, both 
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synergistically and antagonistically. Bacteria combine 
metabolic forces in order to breakdown complex host mac-
romolecules (eg, mucins) in order to obtain nutrients. Food 
chains develop, where the metabolic product of one organism 
becomes a primary nutrient for another. Cell-cell signaling 
occurs using a range of diffusible molecules which facilitates 
the coordination of gene expression among members of the 
microbial community. Peptides are used for communication 
between Gram positive bacteria, while autoinducer 2 is used 
by many Gram negative species. Thus, these oral biofilms 
become structurally and functionally organized,16 and their 
biological properties are greater than the sum of the indi-
vidual species.14 These biofilms are also more tolerant of 
antimicrobial agents and host defenses.
Advances in diagnostic techniques: 
molecular analysis
Conventional approaches
The invention of microscopy and the first use of appropriate 
selective culture media led to the improved isolation and iden-
tification of organisms found in oral biofilms. Early studies 
carried out extensive investigations of the composition of the 
microbiota in order to determine the etiological association 
between specific organisms and oral infection. These stud-
ies revealed an initial picture of the predominant culturable 
species in oral biofilms.18,19 Dental caries was associated 
with increases in acid-producing and acid-tolerating species, 
especially mutans streptococci and lactobacilli, while sites 
with periodontal disease had biofilms with a greater biomass, 
and higher numbers of proteolytic and obligately anaerobic 
bacteria, many of which were Gram negative. Some simple 
cultural “diagnostic” tests were developed using selective 
media for cariogenic bacteria. These tests could be set up in 
the dental surgery, but required a certain amount of equipment 
(eg, incubators) and needed time for the organisms to grow 
to form visible colonies, and so the results were not avail-
able while the patient was present. Generally, further tests to 
confirm the identification of these bacteria were not carried 
out, and so it was assumed that the presence of colonies on 
these selective media was indicative of the presence of these 
putative cariogenic pathogens. Patients with high salivary 
levels of such potentially cariogenic bacteria were designated 
as being at “high risk” for future caries, and were selected for 
additional clinical and therapeutic attention. Various chairside 
testing kits are available and enable rapid detection of such 
cariogenic bacteria.20–22
The culture of periodontal pathogens requires 
much more sophisticated facilities (such as those for 
anaerobic microbiology), and is usually carried out at spe-
cialist centers. These bacteria can take up to 10–14 days 
to grow, but can then be subjected to antibiotic sensitivity 
tests if treatment is required. In periodontal disease, the 
precise identification of certain organisms could be critical; 
for example, a particular clone (JP2) of Aggregatibacter 
actinomycetemcomitans is a major risk factor for local-
ized aggressive periodontitis in young adults,23 but such 
identification is not easy.
Contemporary approaches
As stated earlier, not all of the bacteria in dental biofilms 
can be grown, especially those found in advanced caries 
or subgingivally, while some species are slow-growing or 
require specialist laboratory facilities for their cultivation. 
However, advances in molecular techniques over the past few 
decades have revolutionized our ability to detect and identify 
all micro-organisms in oral biofilms rapidly, including those 
that cannot be cultivated at present.
An example of such a technique was the use of 
polymerase chain reaction (PCR)-based methods in single 
or multiplexed approaches, which involved amplification 
and sequencing of fragments of the 16S rRNA gene or a 
housekeeping gene to help detect bacterial species associated 
with periodontal disease or caries, eg, members of the red 
complex (Porphyromonas gingivalis, Tannerella forsythia, 
and Treponema denticola).24–26 Diagnostic tests such as the 
MicroDent® Test and ParoCheck® kits using this multiplex 
PCR scheme are commercially available from Hain Life-
science GmbH (Nehren, Germany) and Greine Bio-one 
(Stonehouse, UK), respectively, and have been used to com-
pare the microbiota between subgingival plaque samples.24,27,28 
Several other molecular diagnostic tests exist and are provided 
by some clinicians or private companies, eg, MyPerioPath 
test® and oralDNA® (OralDNA Labs, Brentwood, TN, USA) 
and the Integrated Periodontal® test (Biomolecular Diagnostic, 
Florence, Italy).29–31 They all share a common goal, which is 
to support the clinician in the diagnosis of oral diseases, in 
particular periodontal disease. The aim of these tests is to 
provide crucial information for advanced treatment plans and 
therapy for “at risk” patients, and should be used routinely as 
a prevention strategy for healthy patients. However, a major 
issue remains with their cost, which prevents them from being 
used widely on a routine basis. The molecular techniques 
used in these tests are limited to the detection of a selected 
number of pathogens so other important disease factors could 
be missed, because it is now accepted that the disease process 
is highly complex, and pathology arises from the actions of 
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the bacterial communities and from their deregulation of the 
local host response.32
Much research is currently underway to further inves-
tigate oral biofilms using culture-independent approaches, 
and to understand microbial diversity and function as well 
as etiology of disease better. This effort has given rise to the 
development of exciting new molecular methods, which are 
unfortunately currently not available as diagnostic tools, 
because they require laboratory facilities and specialist skills, 
so would be impractical in the clinical setting. However, 
they are essential for future development and improvement 
of diagnostic tests. Examples of these molecular techniques 
include application of DNA probes specific to oral bacterial 
species in checkerboard DNA-DNA hybridization, which 
initially allowed the detection and enumeration of bacterial 
species from up to 43 oral biofilm samples simultaneously.33 
The key advantage of this method was the ability to pro-
cess an increased number of samples without the need for 
culture; however, the technique relied on a limited panel of 
preselected target species which were previously identified 
by cultural studies. Another drawback was the low specificity 
in hybridization that results from using whole genomic DNA 
probes on genetically diverse bacterial species. Nonetheless, 
this technique was widely applied by Socransky and Haffajee to 
explain the complex nature of the oral microbiota.34 A study 
by Ximénez-Fyvie et al using this technique detected all the 
40 taxa in supragingival and subgingival plaque samples, and 
found that Actinomyces species were the most established 
at both oral sites, and also suggested a role of supragingival 
plaque as a reservoir of periodontal pathogens, with a poten-
tial to spread and infect subgingival sites.35
The beginning of the era of culture-independent tech-
niques truly started with the implementation of 16S rRNA-
PCR-cloning-sequencing methodology. Because it was clear 
from early culture studies that not all bacterial species are able 
to grow in culture medium, the ability to sample and identify 
microbiota as accurately as possible would have an impact on 
the improving our understanding of microbiota-host interac-
tions and on obtaining a more accurate picture of the microbial 
diversity in oral biofilms; therefore, such approaches would 
also impact on the future development of diagnostic tests. 
The PCR-cloning-sequencing method consists of amplifying 
the 16S rRNA genes directly from samples, taking advan-
tage of the highly conserved regions found in the molecule. 
Amplicons were then cloned and sequenced via the traditional 
Sanger method. Giovannoni et al initially reported use of this 
technique in a study of microbial marine ecosystems, which 
revealed enormous bacterial phylogenetic diversity between 
members of different independent lineages.36 Since then, 
numerous studies have used this technique to investigate 
oral microbiota profiles associated with health and disease 
in a culture-independent approach.37–40 These studies have 
revealed ever-increasing species richness and complexity of 
oral microbiota, with numerous new operational taxonomic 
the units being discovered. The combined efforts from these 
initial investigations led to the development of the Human 
Oral Microbiome Database, which aims to catalogue all bac-
terial species found in the oral cavity.41 The major work con-
sists of collecting 16S rRNA gene sequences into a database, 
to make them accessible via the Human Oral Microbiome 
Database website.11,41 Such an initiative is relevant for dental 
diagnostics because it creates a complete database of the 
oral microbiota which can then be used as the foundation for 
the future development of diagnostic methods. It originated 
from the Human Microbiome Project, which emphasized 
the necessity to identify the predominant micro-organisms 
in the human microbiome and to determine their relative 
abundance, in order to grasp the full extent of genetic and 
functional potential in human health and disease. Therefore, 
tools and methodologies must be made available to carry 
out the work and to obtain significant and useful clinical 
research data.11,39,42
More recently, a similar database was set up, known as 
CORE, a phylogenetically curated 16S rDNA database of the 
core oral microbiome,43 which claimed to offer improved and 
more robust identification of human oral bacterial 16S rRNA 
gene sequences compared with other methods. Its main goal 
is to provide a comprehensive and minimally redundant col-
lection of oral bacteria at the genus and species level, as well 
as providing support for inferring community divergence and 
analysis of large datasets.
There are strengths and limitations associated with the 
16S rRNA PCR-based technique. Some of its strong points 
include the ability to design specific primers for chosen 
groups of strains, together with its culture-independent 
approach when used in the direct amplification, cloning, and 
Sanger sequencing method, which has considerably refined 
our understanding of bacterial phylogenetic diversity in 
oral biofilms. An accurate definition of the oral microbiota 
in health and disease is essential for the development of 
dental diagnostics. The weaknesses in this method include 
the inability of 16S rRNA gene sequencing to distinguish 
between closely related and highly recombinant species 
such as Neisseria and certain streptococci.44,45 This can be 
improved by use of multilocus sequence typing;46 however, 
there are also issues related to the definition of a species. 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
14
Do et al
Clinical, Cosmetic and Investigational Dentistry 2013:5
Indeed, there have been questions raised concerning the 
validity of using species-level identification,47 because it has 
been recognized that only a limited number of genes might 
be common between members of bacterial species,48 and the 
remaining genes may be important in the disease process and 
thus be excluded from analyses using this technique. Other 
issues with the 16S rRNA technique involve the difficulty 
of extracting DNA from all species and the fact that some 
bacterial species contain more than one copy of the 16S rRNA 
gene, which should perhaps be taken into consideration and 
further investigated when carrying out phylogenetic analy-
ses, because they may be wrongly assumed to be identical. 
Overall, the technique is costly, and the cloning stage is also 
hugely tedious; further, it is limited to low sample numbers 
and only reveals the predominant organisms in a sample. 
Despite these issues, sequencing data have been made pub-
licly available and have helped in the identification of most 
members of the oral microbial community. Through the 
design of probes for detecting hundreds of bacterial species, 
it has helped to expand the range of the checkerboard assay 
into a microarray format, ie, the Human Oral Microbe Iden-
tification Microarray,49 which uses reverse-capture ribosomal 
RNA probes to identify and evaluate the relative abundance 
of 272 oral taxa. Several studies have used the Human Oral 
Microbe Identification Microarray in their investigation of the 
microbial etiology of oral diseases. Colombo et al observed 
a distinct microbial profile between samples from refractory 
periodontitis, severe periodontitis, and healthy patients.49 
The microarray method has also been used in other studies 
for oral bacterial profiling,50,51 and in in vitro multispecies 
microcosm models.52
Next-generation sequencing methods
Recent advances in technology have paved the way for new 
possibilities in microbiome research through the develop-
ment of high-throughput sequencing or next-generation 
sequencing. The pyrosequencing methods (as provided by 
the 454 system [Roche, Basel, Switzerland], the first and 
most widely used next-generation sequencing platform) are 
based on the detection of pyrophosphate released during 
DNA synthesis. First, DNA libraries are constructed from 
the sample, the DNA fragments are then amplified within an 
emulsion, and sequencing by synthesis occurs in a massively 
parallel manner, where visible light is produced and detected, 
generating gigabytes of nucleotide sequence reads data.53 
The data output is then processed through a bioinformat-
ics pipeline, which consists of quality screening to remove 
low-quality reads. The remaining data are separated into 
clusters, and assigned into operational taxonomic units after 
comparison with sequences from available databases, such 
as the Human Oral Microbiome Database or the Ribosomal 
Database Project.54
Initial settings of this technique only produced short 
sequence reads of about 150 base pairs, and hence could 
only enable targeting of a single variable region of the 
16S rRNA gene for taxonomic profiling studies. For example, 
Keijser et al reported an overly diverse microbiota in healthy 
adults than previously recorded (19,000 phyla detected), 
using the V6 region of the 16S rRNA gene.55 More recently, 
with the increase in read length because of improvements 
in technology, larger regions of the gene can be sequenced. 
Some studies have carried out bacterial community profil-
ing using sequences from the hypervariable V5–V6 region, 
hence increasing the phylogenetic resolution.56,57 Saber et al 
observed the microbiota of symptomatic periapical lesions, 
and found that the predominant organisms included anaero-
bic bacteria, with high proportions of streptococci, actino-
myces, and unknown taxa.58 A comparison study between 
pyrosequencing and the Human Oral Microbe Identification 
Microarray was carried out by Ahn et al, determining the oral 
microbiome community profiles of patients with oral cancer 
and in healthy volunteers using both techniques.59 The major 
phyla (Firmicutes, Proteobacteria, Bacteroidetes, Actinobac-
teria, and Fusobacteria) were detected by the two methods; 
however, pyrosequencing provided superior sensitivity in 
the level of identification.
Other studies have used the Illumina platform to perform 
taxonomic profiling by 16S rRNA amplicon sequencing,60,61 
using different hypervariable regions. This next-generation 
sequencing platform uses a different chemistry involving a 
reversible terminator-based method during sequencing by 
synthesis, resulting in shorter read lengths compared with 
the 454 pyrosequencing platform, but yields a much higher 
data output. Recently, the available HiSeq 2500 provided by 
Illumina offers a maximum read length of 2 × 150 base pairs, 
and a data output of up to 600 gigabytes.62
Despite claims of reliability, lower costs, ease of use, 
and shorter time frame of protocols,63 these high-throughput 
techniques require a high level of expertise, and cannot be 
transferred to a clinical setting, especially when complex 
bioinformatic skills and computer power are required to make 
sense of the deluge of data generated. A great advantage of 
these techniques lies in the fact that they are able to deal with 
an increasing number of samples, lowering the cost with the 
use of a multiplexed barcoded sequencing approach, allowing 
numerous samples to be pooled together into a single run. 
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The major limitations remain the short reads produced, and 
the errors in reads sequences which are caused by forma-
tion of amplification artifacts and chimeric sequences from 
PCR with mixed templates. Software and algorithms such 
as PyroNoise64 and deNoiser65 are now available to correct 
these faults and aim to provide a more accurate survey of 
the composition of the oral microbiota. However, in spite 
of performing rigorous quality control steps on the data 
(applying the appropriate parameters from bioinformatics 
correction tools), this technique is not perfect and cannot 
avoid huge overestimation of the real microbial diversity, 
because of sequencing errors. Also, the discriminatory power 
of a single gene or gene fragment, as described earlier, is not 
always sufficient to differentiate accurately between some 
closely related species.
Nevertheless, milestones have been achieved in our 
understanding of the structure and composition of complex 
oral biofilms. Further and deeper knowledge of the metabolic 
activities regulating and governing biological processes at 
the species–species level are now needed in order to uncover 
the mechanism of transition from health to disease, and their 
interaction with the responses of the host. So far, all the 
effort has been focused on identifying members of the oral 
microbiome, and making etiological associations between 
various organisms and oral diseases.
Rather than just determining the taxa present in bio-
films, it may be more useful to understand the functions and 
activities at work. Recent publications have reported such 
attempts, using a metagenomic approach, ie, applying next-
generation sequencing to sequence all the microbial DNA 
within a sample directly, and reconstructing the genomes 
of the microbiota via de novo assembly or mapping against 
a reference genome database. The resulting data can be 
processed further into functional gene annotation, and this 
method is claimed to offer an insight into the global genetic, 
metabolic, and ecological modifications occurring within 
subgingival plaque samples in periodontitis.66
An increase in virulence factors in the disease microbiome 
was also observed, perhaps resulting from or contributing to 
the disruption of microbial homeostasis. Belda-Ferre et al 
identified etiological agents of caries and confirmed the 
view that caries is a polymicrobial disease.8 Their oral 
metagenomic data revealed distinct functional categories 
when compared with the gut microbiome. They also found 
that Streptococcus mutans, a bacterial species widely impli-
cated in the initiation and development of caries, was not the 
predominant species in caries, suggesting that in order to 
understand disease it might be more important to decipher 
microbial function in oral biofilms rather than merely listing 
the taxa that are present. They also observed that the micro-
biome of healthy individuals with no prior history of caries 
showed an overrepresentation of genes involved in quorum 
sensing and coding for antimicrobial peptides.
Luo et al used the 454 and Illumina platforms on the 
same microbial community sample for metagenomic analy-
sis to assess and compare their performance.67 Both these 
high-throughput techniques generated consistent data, but 
Illumina provided longer and more accurate contigs, despite 
yielding shorter read lengths than the 454 platform. As 
well as being more cost-effective, the data obtained from 
Illumina might be more appropriate for carrying out meta-
genomic studies, in particular without the bias associated 
with PCR-based methods and cloning. Nonetheless, there 
are issues associated with direct metagenome sequencing 
because of the sampling protocols used, which cannot 
guarantee inclusion of all microbial species, as well as 
the technique itself, which only yields partial genome 
sequences, inevitably leading to inconsistent annotations.68 
Moreover, it may be incorrect to assume that the func-
tions assigned to the sequenced metagenome are exerted 
within the studied microbiome, without confirmation that 
the genes are actually expressed under the given environ-
mental conditions and time frame. In order to understand 
such complex interactions fully, and capture the subtleties 
of biochemical activities occurring within oral biofilms 
in health and disease, more developments are needed in 
term of tools and technologies. The goal will be to use the 
ever-advancing techniques available to decipher the whole 
meta-transcriptome, meta-proteome, and meta-metabolome. 
The view of microbial communities as one meta-organism 
is appropriate, with all the meta-omic disciplines becoming 
the ultimate target of investigation for understanding the 
cellular processes at work within the biofilm and to link the 
data generated with prediction of functional responses to 
environmental stress. Such developments may conceivably 
accelerate the development of diagnostic tests that rely on 
detection of a small number of disease-specific functions 
in the microbial community, and do not require information 
regarding species composition. However, the major hurdle 
lies in the difficulty in analysis and interpretation of the 
enormous amount of data generated.
Investigations of microbial metatranscriptomes are 
not novel, and numerous studies have applied the RNA-
Seq method to the gut microbiota.69–71 The technique 
consists of extracting mRNA fragments from clinical 
samples and reverse-transcribing them into cDNA which 
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is then sequenced in a high-throughput and massively 
parallel manner. However, this has not been applied to the 
oral microbiome yet.
Recently, an impressive new cutting-edge procedure was 
described by Sherstnev et al, implying direct sequencing of 
RNA extracted from the plant Arabidopsis thaliana, thus 
bypassing the reverse-transcription step.72 The emerging field 
of single-cell genomics is also currently being implemented 
for bacteria and Archaea.73 It may not be long before these 
exciting techniques are also used for further characterization 
of oral biofilms but, until then, diagnostic tests based on 
identification of specific organisms using culture and basic 
molecular methods remain the norm. The issue with these 
commercially available tests is the question of their true value 
in terms of reliability for detecting agents causative of dis-
ease, given our limited knowledge of the complex ecosystem 
involved. The other major concern lies in the ability of the 
clinician or diagnostic company to interpret the results cor-
rectly and in such a way as to provide benefit for patients.
Implications for enhanced  
patient care
Molecular techniques in microbiology have many advantages 
over traditional culture methods. Indeed, they provide more 
accurate results, and with the recent advances in technology, 
have the potential to lead the way to development of more per-
sonalized treatments through a better understanding of genet-
ics, biochemistry, pathogenicity, phylogeny, and microbial 
population structure and evolution. However, only a limited 
number of commercial diagnostic aids are available, and new 
improved kits that give an overall indication of disease status 
(including metabolic pathways and activities) are needed. 
Despite the huge improvement in identification of the composi-
tion of oral biofilms, culture methods will still play an essential 
role in every research laboratory and in the clinical setting, and 
be part of the initial background baseline diagnostic screening 
and analysis steps in assisting patient therapy.
As described in this review, molecular methods for inves-
tigating oral biofilms are not perfect, and come with many 
drawbacks, including cost, their time-consuming nature, and 
the high level of expertise required to process samples and 
carry out data analysis. Also, their impracticality and our 
current inability to use these techniques in a clinical setting 
will impact on the enthusiasm of dentists to implement such 
diagnostic tools, and the benefit to patients from the use of 
such tests still needs to be quantified.
A major obstacle to developing a simple chairside test 
is the huge complexity in procedures implicated in the 
development of diagnostics, which can be time-consuming 
and costly. It is essential that more effort is directed towards 
identifying biomarkers of disease and their role in diagnosis, 
in order to help improve the outcome of patient therapy, and 
to establish a relationship between the mechanism of disease 
progression and therapeutic intervention.
Rather than improving the diagnosis of conventional oral 
diseases, the future of diagnostics in dentistry may be related 
to more holistic medical issues. The ease of sampling oral 
fluids such as saliva and gingival crevicular fluid makes these 
the preferred biological samples for assessing biomarkers.74 
Oral biofilms are also easy for dental professionals to sample, 
and if chairside tests, such as functional property assays, 
were available to enable rapid analysis of biofilm samples, 
this would help guide treatment and therapy. Other important 
factors are the need for further prospective cohort studies and 
standardization of protocols for sample collection and han-
dling, in order to obtain a better comparison between future 
studies. Indeed, improved patient screening and appropriate 
clinical samples would certainly allow a better understand-
ing of health and disease. This will ultimately lead to novel 
therapies and guidance on lifestyle changes, implicating the 
microbiome.
Next-generation sequencing technologies have current 
applications in medical diagnostics, eg, in genetic diseases, 
but they are not yet applied to dentistry. However, with time, 
these advanced technologies will become faster, more accu-
rate, easier to use, and more affordable, which will allow 
clinicians to provide patients with rapid personalized treat-
ment and prevention plans. Moreover, the data generated 
by these advanced molecular techniques may also contain 
human gene information, which together with microbial 
genetic and functional information can provide a more com-
plete understanding of our predisposition to oral diseases. 
There are many public health challenges yet to overcome. 
As mentioned in this review, the main difficulties include 
the polymicrobial nature of oral diseases, and so their non-
specific etiology, the potentially high cost of tests, and the 
specialist skills required for data interpretation. However, 
the public health benefits associated with future prospects 
in dental diagnostics for oral biofilms would include the 
more rational selection of treatment plans through a sys-
tematic differentiation of “active” from “inactive” lesions 
and identification of “at risk” sites. Other benefits would see 
the underpinning of the principles for “minimally invasive 
dentistry”, with the potential for reducing overtreatment, 
and ultimately resulting in cheaper treatments over the life 
of a patient through evidence-based dentistry.
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Despite the great challenges ahead, the combined efforts 
and collaboration of clinicians and researchers will be essential 
in providing a platform for creating future oral diagnostics and 
find applications for moving from bench to clinical practices. It 
is likely that clinicians will have to rely on external companies 
which will be able to accommodate rapid sample processing and 
analyses. Current diagnostic tools only target specific organ-
isms, but future methods will probably depend on a more radical 
shift in disease concepts, and focus on detection of microbial 
functions in oral biofilms rather than microbial names.
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